Glioblastoma (GB) is an aggressive brain cancer, characterized by extensive infiltration and metabolic adaptations, yet not fully understood. Spatial transcriptomics (ST) and spatial metabolomics (and lipidomics) through Mass Spectrometry Imaging (MSI), are two powerful omics modalities that allow to dissect the tissue organisation of this cancer. Our bioinformatics team, led
